Insider · CIK 0002047027
Ravi Mehrotra
Files at OMGA (Omega Therapeutics, Inc.). First filing -, latest -.
Ravi Mehrotra files SEC Form 4 as director at OMGA (Omega Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ravi Mehrotra has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 3, 2024 | OMGA Omega Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Dec 5, 2024 |
Questions about Ravi Mehrotra
Answered from the filings on this page, as of the latest one.
Is Ravi Mehrotra buying or selling?
Ravi Mehrotra has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ravi Mehrotra's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ravi Mehrotra has 0.
Where does Ravi Mehrotra file Form 4?
Ravi Mehrotra has filed Form 4 at OMGA (Omega Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.